The discriminative stimulus properties of U50,488 and morphine are not shared by fedotozine

European Neuropsychopharmacology

Volumn 8, Issue 4, 1998, Pages 261-266

  Broqua, Pierre ^a   Wettstein, Joseph G ^a,b   Rocher, Marie Noëlle ^a   Rivière, Pierre J M ^a,c   Dahl, Svein G ^a  

^a Institut de Recherche Jouveinal   (France)

^b SANOFI   (France)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Drug discrimination; Fedotozine; Kappa opioid agonists; Mu opioid agonists

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; FEDOTOZINE; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR; OPIATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VISCERAL PAIN;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; BENZOFURANS; BENZYL COMPOUNDS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; GENERALIZATION, STIMULUS; MALE; MORPHINE; PROPYLAMINES; PYRROLIDINES; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID, KAPPA;

EID: 0032401253     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00084-9     Document Type: Article

References (26)

1. Allescher H.D., Ahmad S., Classen M., Daniel E.E. Interaction of trimebutine and JO-1196 (fedotozine) with opioid receptors in the canine ileum. J. Pharmacol. Exp. Ther. 257:1991;836-842.
2. Colpaert F.C., Janssen P.A. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization. J. Pharmacol. Exp. Ther. 230:1984;193-199.
3. Diop L., Rivière P.J.M., Pascaud X., Junien J.L. Peripheral K-opioid receptors mediate the antinociceptive effect of fedotozine on the duodenal pain reflex in rat. Eur. J. Pharmacol. 271:1994;65-71.
4. Friese N., Rivière P.J.M., Chevalier E., Angel-Urban F., Pascaud X., Junien J.L. Kappa-agonists such as fedotozine inhibit pain and reverse gastrointestinal transit inhibition induced by peritonitis in rats. Gastroenterology. 106:1994;A501.
5. Friese N., Chevalier E., Angel F., Pascaud X., Junien J.L., Dahl S.G., Rivière P.J.M. Reversal by K-agonists of peritoneal irritation-induced ileus and visceral pain in rats. Life Sci. 60:1996;625-634.
6. Holtzman S.G., Cook L., Steinfels G.F. Discriminative stimulus effects of spiradoline, a kappa-opioid agonist. Psychopharmacology. 105:1991;447-452.
7. Hunter J.C., Leighton G.E., Meecham K.G., Boyle S.J., Horwell D.C., Rees D.C., Hughes J. CI-977, a novel and selective agonist for the K-opioid receptor. Br. J. Pharmacol. 101:1990;183-189.
8. Karaus M., Kittelman R., Lubke H.J., Erkenbrecht J.F. Selective stimulation of phase 3 activity by fedotozine (JO 1196) in man. Gastroenterology. 98:1990;A364.
9. 1b subtype. Neuroreport. 5:1994;2161-2164.
10. Langlois A., Diop L., Rivière P.J.M., Pascaud X., Junien J.L. Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anaesthetized rat. Eur. J. Pharmacol. 271:1994;245-251.
11. Langlois A., Diop L., Friese N., Pascaud X., Junien J.L., Dahl S.G., Rivière P.J.M. Fedotozine blocks colonic hypersensitivity in conscious rats: action at peripheral K-opioid receptors. Eur. J. Pharmacol. 318:1997;141-144.
12. Leander J.D. Further study of kappa opioids on increased urination. J. Pharmacol. Exp. Ther. 227:1983;35-41.
13. Millan M.J. Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious, thermal, pressure and electrical stimuli. J. Pharmacol. Exp. Ther. 251(1):1989;334-341.
14. Negus S.S., Picker M.J., Dykstra L.A. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure. Psychopharmacology. 102:1990;465-473.
15. Pascaud X., Honde C., Le Gallou B., Chanoine F., Roman F., Bueno L., Junien J.L. Effects of fedotozine on gastrointestinal motility in dogs: mechanism of action and related pharmacokinetics. J. Pharm. Pharmacol. 42:1990;546-552.
16. Picker M.J., Doty P., Negus S.S., Mattox S.R., Dykstra L.A. Discriminative stimulus properties and U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. J. Pharmacol. Exp. Ther. 254:1990;13-22.
17. Rivière P.J.M., Pascaud X., Le Gallou B., Junien J.L. Effects of fedotozine (JO 1196) on intestinal motility in rats. Gastroenterology. 100:1991;A487.
18. Rivière P.J.M., Pascaud X., Chevalier E., Le Gallou B., Junien J.L. Fedotozine reverses ileus induced by surgery or peritonitis: action at peripheral K-opioid receptors. Gastroenterology. 104:1993;724-731.
19. Rivière P.J.M., Pascaud X., Chevalier E., Junien J.L. Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents. J. Pharmacol. Exp. Ther. 270:1994;846-850.
20. Sengupta J.N., Su X., Gebhart G.F. K, but not μ or δ, opioids attenuate responses to distention of afferent fibers innervating the rat colon. Gastroenterology. 111:1996;968-980.
21. Shannon H.E., Holtzman S.G. Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology. 61:1979;239-244.
22. Smith M.A., Picker M.J. Examination of the kappa agonist and antagonist properties of opioids in the rat drug discrimination procedure: influence of training dose and intrinsic efficacy. Behav. Pharmacol. 6:1995;703-717.
23. Shearman G.T., Herz A. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate K-receptor agonists. Psychopharmacology. 78:1982;63-66.
24. Soulard C.D., Guerif S., Payne A., Dahl S.G. Differential effects of fedotozine compared to other kappa agonists on diuresis in rats. J. Pharmacol. Exp. Ther. 279:1996;1379-1385.
25. Von Voigtlander P.F., Lahti R.A., Ludens J.H. U50,488: a selective and structurally novel non-M (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224:1983;7-12.
26. Young A.M., Masaki M.A., Geula C. Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J. Pharmacol. Exp. Ther. 261:1992;246-257.